The study also showed that treating lupus patient T cells ex vivo with inhibitors of miR-21 and miR-148a could increase DNMT1 levels and partially reverse DNA hypomethylation, bringing the methylation status of genes closer to that in healthy T cells (18). The gene discussed is DNMT1; the disease is systemic lupus erythematosus.